Prologis director sells 621 shares in Rule 10b5-1 stock trade

Prologis, Inc. reported an insider stock transaction by one of its directors.

Rhea-AI Filing Summary

Prologis, Inc. reported an insider stock transaction by one of its directors. On 12/01/2025, the director sold 621 shares of Prologis common stock at a price of $127.60 per share in a transaction coded as a sale. After this trade, the director beneficially owned 8,208 shares of Prologis common stock in direct ownership. The filing notes that the transaction was carried out under a pre-arranged Rule 10b5-1 trading plan dated August 1, 2025, which is designed to allow insiders to sell shares according to a set schedule.

Insider Trade Summary

Net Seller: 621 shares

Net Sell 1 txn

Insider BITA CRISTINA GABRIELA

Role Director

Sold 621 shs ($79K)

Type	Security	Shares	Price	Value
Sale	Common Stock	621	$127.60	$79K

Holdings After Transaction: Common Stock — 8,208 shares (Direct)

Footnotes (1)

1. F1. THIS TRANSACTION WAS CONDUCTED IN CONNECTION WITH A 10B5-1 PLAN DATED AUGUST 1, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Prologis (PLD) disclose in this Form 4?

A director of Prologis, Inc. reported selling 621 shares of common stock on 12/01/2025 in a transaction coded as a sale.

At what price were the Prologis (PLD) shares sold in this insider trade?

The director sold the 621 shares of Prologis common stock at a price of $127.60 per share.

How many Prologis (PLD) shares does the reporting person own after the sale?

Following the reported transaction, the director beneficially owned 8,208 shares of Prologis common stock with direct ownership.

Was the Prologis (PLD) insider sale under a Rule 10b5-1 trading plan?

Yes. The filing states that the transaction was conducted under a Rule 10b5-1 plan dated August 1, 2025.

What is the reporting person’s relationship to Prologis (PLD)?

The reporting person is identified as a director of Prologis, Inc. and is filing the Form 4 as a single reporting person.

Does this Prologis (PLD) Form 4 report any derivative securities?

No derivative securities are reported in Table II; only a sale of common stock is shown in Table I.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/02/2025 - 05:30 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BITA CRISTINA GABRIELA

(Last) (First) (Middle)

C/O PROLOGIS, INC., PIER 1, BAY 1

(Street)

SAN FRANCISCO CA 94111

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Prologis, Inc. [ PLD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	12/01/2025	12/01/2025	S		621	D	$127.6	8,208	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. THIS TRANSACTION WAS CONDUCTED IN CONNECTION WITH A 10B5-1 PLAN DATED AUGUST 1, 2025.

	/s/ Tammy Colvocoresses Attorney-In-Fact for Cristina G. Bita	12/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.